Navigation Links
Statin Therapy Helps Diabetic Patients
Date:1/11/2008

British study finds cholesterol-lowering drugs reduce risk of major vascular events

FRIDAY, Jan. 11 (HealthDay News) -- Most people with diabetes should be considered for treatment with cholesterol-lowering statins.

That's the advice of the authors of a study in the Jan. 12 issue of The Lancet.

The British and Australian researchers found that statins reduced the risk of major vascular events in a wide range of people with diabetes, regardless of age, sex and other clinical characteristics, and irrespective of whether they already had cardiovascular disease.

Diabetes is associated with an increased risk of cardiovascular disease.

For the study, the researchers conducted a meta-analysis of 18,686 people with diabetes and 71,370 without diabetes who took part in 14 randomized trials that examined the use of statins to reduce levels of low-density lipoprotein (LDL), or "bad" cholesterol.

During a mean follow-up of 4.3 years, 3,247 of the people with diabetes experienced vascular events. Among people with diabetes, there was a 9 percent proportional reduction in all-cause death per mmol/L reduction in LDL cholesterol, which was similar to the 13 percent reduction noted in people without diabetes.

The study authors said they found a significant 20 percent proportional reduction in major vascular events per mmol/L reduction in LDL cholesterol in people with diabetes, a decline similar to that seen in people without diabetes.

"This meta-analysis shows convincingly that the proportional benefits of statin therapy on major vascular events were similar in a wide range of individuals with diabetes, including those with no previous history of vascular disease, and benefits were similar to those observed in people without diabetes," the researchers wrote.

"Most people with diabetes should now be considered for statin therapy, unless their risk is low (e.g., as in children) or statin therapy has been shown to be unsuitable for them (e.g., as in pregnancy)," they concluded.

Statins are among the most notable achievements of modern medicine, but "one must not forget the importance of lifestyle changes, such as cessation of smoking, healthy diet, and regular exercise," Bernard Cheung, a professor of clinical pharmacology at the University of Birmingham in the United Kingdom, wrote in a commentary accompanying the study.

More information

The American Heart Association has more about statins.



-- Robert Preidt



SOURCE: The Lancet, news release, Jan. 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA Advisers Reject Over-the-Counter Statin
2. FDA Panel Considering Over-the-Counter Statin
3. FDA Panel to Consider Over-the-Counter Statin
4. Scientists identify gene responsible for statin-induced muscle pain
5. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
6. Burn injuries take devastating toll on nations children
7. Statins After Bypass Lower Stroke Risk
8. Congress called on to replace devastating cuts in Medicare reimbursements by ACP
9. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
10. Better Prostate Cancer Survival for Men Taking Statins
11. Statins reduce loss of function, keeping old lungs young - even in smokers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to ... which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping ... prolonging life 6 years in the last 3 decades,” says Dr. Valentine Fuster, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, Inc. ... the first company to offer robotic imaging to veterinary medicine is sponsoring the ... 941 for the American Association of Equine Practitioners 62nd Annual Convention from December ...
(Date:12/2/2016)... ... ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, has published ... Yisrayl says this generation, known as the Last Generation, started in 1934 A.Y. (After ... up exactly with Bible Prophecy – a protected way for those who will believe. ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... National Pharmacy Services, LLC ("Maxor"), today announced that it has ... of Texas -based Maxor Specialty / IV ... both company,s clinical expertise and high-touch patient service models to ... About Maxor ... , , Established ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific Corporation ... agreement to acquire certain manufacturing assets and capabilities of ... NVC) advanced biological tissue business, as well as a ... $75 million in cash. The Neovasc advanced biological tissue ... the Boston Scientific Lotus™ Valve System. * Upon ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology: